Search Site
  • 0
    My Cart

    Click Here to Find How Many Items You Have Added:)

    image loader

    Adding item(s) to cart......

Home >> Signaling Pathways >> Cardiovascular

Cardiovascular

Cardiovascular

Cardiovascular

The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment.

Targets for  Cardiovascular

Products for  Cardiovascular

  1. Cat.No. Product Name Information
  2. GC45198 α-CGRP (8-37) (human) (trifluoroacetate salt)

    Calcitonin Gene-Related Peptide-1 (8-37) (human), CGRP-1 (8-37) (human), α-Calcitonin Gene-Related Peptide (8-37) (human)

     Calcitonin gene-related protein (CGRP) is a neuropeptide and a product of alternative splicing of the calcitonin gene. α-CGRP (8-37) (human) (trifluoroacetate salt) Chemical Structure
  3. GC45200 α-CGRP (rat) (trifluoroacetate salt)

    Calcitonin Gene-Related Peptide-1 (rat), α-Calcitonin Gene-Related Peptide (rat), CGRP-1 (rat)

     α-Calcitonin gene-related peptide (α-CGRP) is a neuropeptide with roles in vasodilation, cardiovascular regulation, and inflammation. α-CGRP (rat) (trifluoroacetate salt) Chemical Structure
  4. GC45208 α-hydroxy Metoprolol α-hydroxy Metoprolol is an active metabolite of the β1-adrenergic receptor blocker metoprolol. α-hydroxy Metoprolol Chemical Structure
  5. GC48283 α-Linolenic Acid-d14

    ALAd14

     An internal standard for the quantification of αLinolenic acid α-Linolenic Acid-d14 Chemical Structure
  6. GC45602 α-Linolenic Acid-d5 MaxSpec• Standard

    ALA-d5, C18:3 (9Z,12Z,15Z)-d5, C18:3 n-3-d5

       α-Linolenic Acid-d5 MaxSpec• Standard Chemical Structure
  7. GC49467 β-Aescin A triterpenoid saponin with diverse biological activities β-Aescin Chemical Structure
  8. GC49890 β-Glycerophosphate-d5 (sodium salt hydrate)

    Glycerol 2-Phosphate-d5

     An internal standard for the quantification of β-glycerophosphate β-Glycerophosphate-d5 (sodium salt hydrate) Chemical Structure
  9. GC40105 βARK1 Inhibitor βARK1 Inhibitor (methyl 5-[2-(5-nitro-2-furyl)vinyl]-2-furoate) is a GRK2 (β-ARK1) inhibitor. βARK1 Inhibitor Chemical Structure
  10. GC52400 γ-Glu-Ala (trifluoroacetate salt)

    γ-Glutamylalanine, γ-L-Glutamyl-L-alanine

     A dipeptide γ-Glu-Ala (trifluoroacetate salt) Chemical Structure
  11. GC52404 γ-Glu-Phe (trifluoroacetate salt)

    γ-Glutamylphenylalanine

     A dipeptide with metabolism-altering activity γ-Glu-Phe (trifluoroacetate salt) Chemical Structure
  12. GC41393 ω-3 Arachidonic Acid methyl ester ω-3 Fatty acids, represented primarily by docosahexaenoic acid, eicosapentaenoic acid, and α-linoleate, are essential dietary nutrients required for normal growth and development. ω-3 Arachidonic Acid methyl ester Chemical Structure
  13. GC41661 (±)-4-hydroxy Propranolol β-D-Glucuronide (±)-4-hydroxy Propranolol β-D-glucuronide is a metabolite of (±)-4-hydroxy propranolol, which is a metabolite of propranolol. (±)-4-hydroxy Propranolol β-D-Glucuronide Chemical Structure
  14. GC46273 (±)-Atenolol-d7

    (R,S)-Atenolol-d7, Duraatenol, ICI 66082

     An internal standard for the quantification of (±)-atenolol (±)-Atenolol-d7 Chemical Structure
  15. GC46289 (±)-Felodipine-d5 An internal standard for the quantification of (±)-felodipine (±)-Felodipine-d5 Chemical Structure
  16. GC46304 (±)-Nebivolol-d4 (hydrochloride) A neuropeptide with diverse biological activities (±)-Nebivolol-d4 (hydrochloride) Chemical Structure
  17. GC90022 (±)-Norepinephrine-d6 (hydrochloride)

    An internal standard for the quantification of norepinephrine

     (±)-Norepinephrine-d6 (hydrochloride) Chemical Structure
  18. GC46307 (±)-Propranolol-d7 An internal standard for the quantification of propranolol (±)-Propranolol-d7 Chemical Structure
  19. GC46312 (±)-Verapamil-d3 (hydrochloride)

    (±)-Verapamil-d3 hydrochloride; CP-16533-1-d3 hydrochloride

     A neuropeptide with diverse biological activities (±)-Verapamil-d3 (hydrochloride) Chemical Structure
  20. GC40229 (±)-Warfarin-d5 (±)-Warfarin-d5 is intended for use as an internal standard for the quantification of warfarin by GC- or LC-MS. (±)-Warfarin-d5 Chemical Structure
  21. GC40386 (±)11(12)-EpETE

    (±)11,12-EEQ, (±)11,12-Epoxyeicosatetraenoic Acid

     Eicosapentaenoic acid is converted to epoxyeicosatetraenoic acids (EpETE) by several cytochrome P450 isoforms. (±)11(12)-EpETE Chemical Structure
  22. GC40467 (±)11-HETE

    (±)11-Hydroxyeicosatetraenoic Acid

     (±)11-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. (±)11-HETE Chemical Structure
  23. GC91065 (±)13,14-EDT

    A metabolite of adrenic acid

     (±)13,14-EDT Chemical Structure
  24. GC41649 (±)13-HODE cholesteryl ester (±)13-HODE cholesteryl ester was originally extracted from atherosclerotic lesions and shown to be produced by Cu2+-catalyzed oxidation of LDL. (±)13-HODE cholesteryl ester Chemical Structure
  25. GC40268 (±)14(15)-DiHET

    (±)14,15DiHETrE

     Epoxide hydrolases convert the EETs into vicinal diols, with the concurrent loss of much of their biological activity. (±)14(15)-DiHET Chemical Structure
  26. GC40430 (±)14(15)-EET

    (±)14,15-EET, (±)14,15-EpETrE

    (±)14(15)-EET is biosynthesized in rat and rabbit liver microsomes by CYP450.

     (±)14(15)-EET Chemical Structure
  27. GC40835 (±)14(15)-EET methyl ester

    (±)14,15EpETrE methyl ester

     (±)14(15)-EET is biosynthesized in rat and rabbit liver microsomes by CYP450. (±)14(15)-EET methyl ester Chemical Structure
  28. GC41651 (±)14(15)-EET-SI

    14,15-EpETrE-SI, 14(15)-EET-SI, 14(15)EETsulfonimide

     Arachidonic acid is metabolized in the vascular endothelium to epoxytrienoic acids (EETs or EpETrEs) by cytochrome P450 enzymes. (±)14(15)-EET-SI Chemical Structure
  29. GC91067 (±)16,17-EDT

    A metabolite of adrenic acid

     (±)16,17-EDT Chemical Structure
  30. GC40434 (±)16-HETE

    (±)16-Hydroxyeicosatetraenoic Acid

     Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites. (±)16-HETE Chemical Structure
  31. GC46260 (±)17(18)-EpETE

    (±)17,18-EEQ, (±)17,18-epoxy Eicosatetraenoic Acid

     A neuropeptide with diverse biological activities (±)17(18)-EpETE Chemical Structure
  32. GC41288 (±)17(18)-EpETE-Ethanolamide

    17,18-EEQ-EA, (±)17,18-EEQ-Ethanolamide, (±)17(18)-EpETE-EA, 17,18-epoxy-Eicosatetraenoic Acid Ethanolamide

     (±)17(18)-EpETE-Ethanolamide is an ω-3 endocannabinoid epoxide. (±)17(18)-EpETE-Ethanolamide Chemical Structure
  33. GC40362 (±)18-HEPE (±)18-HEPE is produced by non-enzymatic oxidation of EPA. (±)18-HEPE Chemical Structure
  34. GC40436 (±)18-HETE

    (±)18-Hydroxyeicosatetraenoic Acid

     (±)18-HETE is the racemic version of a cytochrome P450 (CYP450) metabolite of arachidonic acid. (±)18-HETE Chemical Structure
  35. GC41655 (±)19(20)-EDP Ethanolamide

    19,20-DHEA epoxide, 19,20-epoxy Docosapentaenoic Acid Ethanolamide, 19,20-EDP-EA, 19,20-EDP epoxide

     (±)19(20)-EDP ethanolamide is an ω-3 endocannabinoid epoxide and cannabinoid (CB) receptor agonist (EC50s = 108 and 280 nM for CB1 and CB2, respectively). (±)19(20)-EDP Ethanolamide Chemical Structure
  36. GC40437 (±)5(6)-DiHET lactone

    (±)5,6DiHETrE lactone

     5,6-DiHET lactone is a lactonized form of 5,6-EET and 5,6-DiHET. (±)5(6)-DiHET lactone Chemical Structure
  37. GC40438 (±)5(6)-EET

    (±)5,6EpETrE

     5(6)-EET is a fully racemic version of the enantiomeric forms biosynthesized from arachidonic acid by cytochrome P450 enzymes. (±)5(6)-EET Chemical Structure
  38. GC40421 (±)8(9)-EE-14(Z)-E

    (±)8,9-Epoxyeicosa-14(Z)-enoic Acid

     (±)14(15)-EE-8(Z)-E is a potent vasodilator in bovine coronary arteries. (±)8(9)-EE-14(Z)-E Chemical Structure
  39. GC41665 (±)8(9)-EET Ethanolamide

    (±)8,9-EET Ethanolamide

     Arachidonoyl ethanolamide (AEA; anandamide) is an endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. (±)8(9)-EET Ethanolamide Chemical Structure
  40. GC40443 (±)9-HETE

    (±)9-Hydroxyeicosatetraenoic Acid

     (±)9-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. (±)9-HETE Chemical Structure
  41. GC40541 (±)9-HODE

    (±)9-HODE is one of the two racemic monohydroxy fatty acids resulting from the non-enzymatic oxidation of linoleic acid.

     (±)9-HODE Chemical Structure
  42. GC41666 (±)9-HODE cholesteryl ester (±)9-HODE cholesteryl ester was originally extracted from atherosclerotic lesions and shown to be produced by Cu2+-catalyzed oxidation of LDL. (±)9-HODE cholesteryl ester Chemical Structure
  43. GC40356 (±)9-HpODE (±)9-HpODE is a racemic mixture of the fatty acid hydroperoxide product (9(S)-HpODE) formed from lipoxygenase action on linoleic acid. (±)9-HpODE Chemical Structure
  44. GC70332 (+)-Erinacin A (+)-Erinacin A is an anticancer compound that can be isolated from the mushroom Hericium erinaceum. (+)-Erinacin A Chemical Structure
  45. GC49690 (3R,5R)-Rosuvastatin (calcium salt) A potential impurity found in bulk preparations of rosuvastatin (3R,5R)-Rosuvastatin (calcium salt) Chemical Structure
  46. GC41694 (3S)-hydroxy Quinidine (3S)-hydroxy Quinidine is an active quinidine metabolite. (3S)-hydroxy Quinidine Chemical Structure
  47. GC48508 (4-Carboxybutyl-d4)triphenylphosphonium (bromide)

    TPP-d4, 5-Triphenylphosphoniovaleric Acid-d4

     An internal standard for the quantification of (4-carboxybutyl)triphenylphosphonium (4-Carboxybutyl-d4)triphenylphosphonium (bromide) Chemical Structure
  48. GC40444 (5Z,11Z,15R)-15-Hydroxyeicosa-5,11-dien-13-ynoic Acid

    HETE Analog 1, Hydroxyeicosatetraenoic Acid Analog 1

     (5Z,11Z,15R)-15-Hydroxyeicosa-5,11-dien-13-ynoic acid is a stable isomer of 15(S)-HETE, a major arachidonic acid metabolite from the 15-lipoxygenase pathway. (5Z,11Z,15R)-15-Hydroxyeicosa-5,11-dien-13-ynoic Acid Chemical Structure
  49. GC41696 (Ala1)-PAR4 (1-6) (mouse) (trifluoroacetate salt)

    H-Ala-Tyr-Pro-Gly-Lys-Phe-OH, AYPGKF

     (Ala1)-PAR4 (1-6) is a synthetic peptide agonist of proteinase-activated receptor 4 (PAR4) that corresponds to residues 1-6 of the amino terminal tethered ligand sequence of mouse PAR4 and residues 60-65 of the full-length sequence with an alanine residue substituted for glycine at position 1/60. (Ala1)-PAR4 (1-6) (mouse) (trifluoroacetate salt) Chemical Structure
  50. GC41697 (Ala1)-PAR4 (1-6) amide (mouse) (trifluoroacetate salt)

    AY-NH2, AYPGKF-NH2, H-Ala-Tyr-Pro-Gly-Lys-Phe-NH2, PAR4-AP, Proteinase-Activated Receptor 4 Activating Peptide

     (Ala1)-PAR4 (1-6) amide (mouse) is a peptide agonist of proteinase-activated receptor 4 (PAR4) that induces aggregation of rat and human platelets in vitro (EC50s = 15 and 60 μM, respectively). (Ala1)-PAR4 (1-6) amide (mouse) (trifluoroacetate salt) Chemical Structure
  51. GC49003 (E)-Ajoene

    NSC 614554

     A disulfide with diverse biological activities (E)-Ajoene Chemical Structure
  52. GC46336 (E)-Guggulsterone A farnesoid X receptor antagonist (E)-Guggulsterone Chemical Structure
  53. GC41704 (Glp1)-Apelin-13 (trifluoroacetate salt)

    (pGlu1)Apelin13, PyrApelin13, (Pyr1)Apelin13

     The apelin gene encodes a pre-proprotein that is processed to generate bioactive peptides consisting of 36, 17, or 13 amino acids: apelin-36, apelin-17, and apelin-13, respectively. (Glp1)-Apelin-13 (trifluoroacetate salt) Chemical Structure
  54. GC40552 (R)-Acenocoumarol

    (R)Acenocoumarin, (R)Nicoumalone

     Acenocoumarol is a short-lived oral anti-coagulant, which, like warfarin, functions by inhibiting vitamin K epoxide reductase. (R)-Acenocoumarol Chemical Structure
  55. GC41722 (R,S)-Carvedilol Glucuronide (R,S)-Carvedilol glucuronide is a racemic mixture of the carvedilol metabolites (R)-carvedilol glucuronide and (S)-carvedilol glucuronide. (R,S)-Carvedilol Glucuronide Chemical Structure
  56. GC46346 (S)-(+)-Clopidogrel-d3 (sulfate) A neuropeptide with diverse biological activities (S)-(+)-Clopidogrel-d3 (sulfate) Chemical Structure
  57. GC40553 (S)-Acenocoumarol

    (S)Acenocoumarin, (S)Nicoumalone

     Acenocoumarol is a short-lived oral anti-coagulant, which, like warfarin, functions by inhibiting vitamin K epoxide reductase. (S)-Acenocoumarol Chemical Structure
  58. GC48719 (S)-Canadine

    (-)-Canadine, (S)-Tetrahydroberberine

     (S)-Canadine is an alkaloid and intermediate in the biosynthesis of berberine with insecticidal activity. (S)-Canadine Chemical Structure
  59. GC19824 (±)-Pinocembrin

    (+)-Pinocembrin, Dihydrochrysin, NSC 279005

     (±)-Pinocembrin ((±)-5,7-Dihydroxyflavanone) is a GPR120 ligand able to promote wound healing in HaCaT cell line. (±)-Pinocembrin Chemical Structure
  60. GC49034 1(R)-(Trifluoromethyl)oleyl alcohol An oleic acid analog 1(R)-(Trifluoromethyl)oleyl alcohol Chemical Structure
  61. GC92074 1,2,3-Trioleoyl Glycerol-d5

    Glyceryl Trioleate-d5; TG(18:1/18:1/18:1)-d5; Triolein-d5

     1,2,3-Trioleoyl glycerol-d5 is intended for use as an internal standard for the quantification of 1,2,3-trioleoyl glycerol by GC- or LC-MS. 1,2,3-Trioleoyl Glycerol-d5 Chemical Structure
  62. GC41837 1,3,7-Trimethyluric Acid

    8-oxo Caffeine, NSC 11259

    1,3,7-Trimethyluric acid is a methyl derivative of uric acid and a product of C-8 oxidation of caffeine by cytochrome P450 enzymes.

     1,3,7-Trimethyluric Acid Chemical Structure
  63. GC46387 1,3,7-Trimethyluric Acid-d9

    TMU-d9, 8-oxo Caffeine-d9

     An internal standard for the quantification of 1,3,7-trimethyluric acid 1,3,7-Trimethyluric Acid-d9 Chemical Structure
  64. GC41846 1,3-Dioctanoyl-2-Oleoyl-rac-glycerol

    1,3-Caprylin-2-Olein, 1,3-Dicapryloyl-2-Oleoyl Glycerol, TG(8:0/18:1/8:0), 8:0/18:1/8:0-TG

     1,3-Dioctanoyl-2-oleoyl-rac-glycerol is a triacylglycerol that contains octanoic acid at the sn-1 and sn-3 positions and oleic acid at the sn-2 position. 1,3-Dioctanoyl-2-Oleoyl-rac-glycerol Chemical Structure
  65. GC49346 1-(3-Chlorophenyl)biguanide (hydrochloride)

    m-Chlorophenylbiguanide hydrochloride, meta-Chlorophenylbiguanide, m-CPBG, meta-CPBG

     A 5-HT3 receptor agonist 1-(3-Chlorophenyl)biguanide (hydrochloride) Chemical Structure
  66. GC18235 1-O-Hexadecyl-sn-glycerol

    α-Chimyl Alcohol, (S)-(+)-Chimyl Alcohol

    1-O-Hexadecyl-sn-glycerol is a bioactive alkyl glyceryl ether.

     1-O-Hexadecyl-sn-glycerol Chemical Structure
  67. GC42008 1-Octadecyl Lysophosphatidic Acid

    1Octadecyl LPA

     1-Octadecyl lysophosphatidic acid (1-octadecyl LPA) is a LPA analog containing stearic acid at the sn-1 position. 1-Octadecyl Lysophosphatidic Acid Chemical Structure
  68. GC92019 1-Octadecyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt)

    LPA O-18:0; O-18:0 LPA; 1-Octadecyl-2-hydroxy-sn-glycero-3-PA; 1-Octadecyl LPA; 1-Octadecyl Lysophosphatidic Acid; 1-Oleyl LPA; 1-Oleyl Lysophosphatidic Acid; PA(O-18:0/0:0); 1-Stearyl-2-hydroxy-sn-glycero-3-PA

     1-Octadecyl-2-hydroxy-sn-glycero-3-phosphate (1-Octadecyl LPA) is a LPA analog containing stearyl alcohol at the sn-1 position. 1-Octadecyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt) Chemical Structure
  69. GC49071 1-Palmitoyl-d9 Lysophosphatidic Acid

    1-Palmitoyl-d9 LPA

     An internal standard for the quantification of 1-palmitoyl lysophosphatidic acid 1-Palmitoyl-d9 Lysophosphatidic Acid Chemical Structure
  70. GC46494 1-Stearoyl-2-Arachidonoyl-d11-sn-glycero-3-PC

    18:0/20:4-d11-PC, PC(18:0/20:4-d11), SAPC-d11, 1-Stearoyl-2-Arachidonoyl-d11-sn-glycero-3-Phosphatidylcholine, 1-Stearoyl-2-Arachidonoyl-d11-sn-glycero-3-Phosphocholine

     A neuropeptide with diverse biological activities 1-Stearoyl-2-Arachidonoyl-d11-sn-glycero-3-PC Chemical Structure
  71. GC46496 1-Stearoyl-2-Arachidonoyl-d8-sn-glycero-3-PC

    18:0/20:4-d8-PC, PC(18:0/20:4-d8), SAPCd8, 1-Stearoyl-2-Arachidonoyl-d8-sn-glycero-3-Phosphatidylcholine, 1-Stearoyl-2-Arachidonoyl-d8-sn-glycero-3-Phosphocholine

     An internal standard for the quantification of 1-stearoyl-2-arachidonoyl-sn-glycero-3-PC 1-Stearoyl-2-Arachidonoyl-d8-sn-glycero-3-PC Chemical Structure
  72. GC49733 1-Stearoyl-2-eicosapentaenoyl-sn-glycero-3-PC

    1-Octadecanoyl-1-Eiocosapentaenoyl-sn-glycero-3-Phosphatidylcholine, 1-Octadecanoyl-1-Eiocosapentaenoyl-sn-glycero-3-Phosphocholine, PC(18:0/20:5), 18:0/20:5-PC

     A phospholipid 1-Stearoyl-2-eicosapentaenoyl-sn-glycero-3-PC Chemical Structure
  73. GC49118 10-hydroxy Warfarin A metabolite of (R)-warfarin 10-hydroxy Warfarin Chemical Structure
  74. GC46408 11-dehydro Thromboxane B2-d4

    11-dehydro TXB2-d4, 11keto TXB2d4

     An internal standard for the quantification of 11dehydro thromboxane B2 11-dehydro Thromboxane B2-d4 Chemical Structure
  75. GC18634 11-deoxy Prostaglandin E1

    11deoxy PGE1

     11-deoxy Prostaglandin E1 (11-deoxy PGE1) is a synthetic analog of PGE1. 11-deoxy Prostaglandin E1 Chemical Structure
  76. GC41401 11-deoxy Prostaglandin F1α

    11deoxy PGF1α

     11-deoxy PGF1α is a synthetic analog of PGF1α. 11-deoxy Prostaglandin F1α Chemical Structure
  77. GC41402 11-deoxy Prostaglandin F1β

    9β,11deoxy PGF1α, 11deoxy PGF1β

     11-deoxy PGF1β is a synthetic analog of PGF1β. 11-deoxy Prostaglandin F1β Chemical Structure
  78. GC92076 119-23 119-23 is an ionizable cationic lipid that has been used in the generation of lipid nanoparticles (LNPs) for the delivery of mRNA in vivo. 119-23 Chemical Structure
  79. GC18637 11β-Prostaglandin F2α

    9α,11βPGF2α, 11βPGF2α, 11epi PGF2α

    11β-Prostaglandin F2α (11β-PGF2α) is the primary plasma metabolite of PGD2 in vivo.

     11β-Prostaglandin F2α Chemical Structure
  80. GC41882 12(S)-HETrE 12(S)-HETrE is produced by 12-lipoxygenase oxidation of dihomo-γ-linolenic acid (DGLA). 12(S)-HETrE Chemical Structure
  81. GC41893 13(R)-HODE cholesteryl ester 13(R)-HODE cholesteryl ester was originally extracted from atherosclerotic lesions. 13(R)-HODE cholesteryl ester Chemical Structure
  82. GC41895 13(S)-HODE cholesteryl ester 13(S)-HODE cholesteryl ester was originally extracted from atherosclerotic lesions. 13(S)-HODE cholesteryl ester Chemical Structure
  83. GC41897 13(S)-HOTrE 13(S)-HOTrE is the 15-lipoxygenase (15-LO) product of linolenic acid. 13(S)-HOTrE Chemical Structure
  84. GC40745 13,14-dehydro-15-cyclohexyl Carbaprostacyclin 13,14-dehydro-15-cyclohexyl Carbaprostacyclin is a chemically stable analog of PGI2. 13,14-dehydro-15-cyclohexyl Carbaprostacyclin Chemical Structure
  85. GC41433 13,14-dihydro Prostaglandin E1

    PGE0, 13,14-dihydro PGE1

     13,14-dihydro Prostaglandin E1 (13,14-dihydro PGE1) is a biologically active metabolite of PGE1 with comparable potency to the parent compound. 13,14-dihydro Prostaglandin E1 Chemical Structure
  86. GC46421 13,14-dihydro Prostaglandin E1-d4

    13,14dh PGE1d4, Prostaglandin E0D4

     A neuropeptide with diverse biological activities 13,14-dihydro Prostaglandin E1-d4 Chemical Structure
  87. GC46425 13,14-dihydro-15-keto Prostaglandin E1-d4

    13,14dh15k PGE1d4

     A neuropeptide with diverse biological activities 13,14-dihydro-15-keto Prostaglandin E1-d4 Chemical Structure
  88. GC40424 14,15-EE-5(Z)-E

    14,15Epoxyeicosa5(Z)enoic Acid

     Epoxyeicosatrienoic acids (EETs), such as 11(12)-EET and 14(15)-EET, are cytochrome P450 metabolites of arachidonic acid that have been identified as endothelium-derived hyperpolarizing factors with vasodilator activity. 14,15-EE-5(Z)-E Chemical Structure
  89. GC40425 14,15-EE-8(Z)-E

    14,15Epoxyeicosa8(Z)enoic Acid

     Epoxyeicosatrienoic acids (EETs), such as 11(12)-EET and 14(15)-EET, are cytochrome P450 metabolites of arachidonic acid that have been identified as endothelium-derived hyperpolarizing factors with vasodilator activity. 14,15-EE-8(Z)-E Chemical Structure
  90. GC46438 14S(15R)-EET

    14S,15R-EpETrE

     A cytochrome P450 metabolite of arachidonic acid 14S(15R)-EET Chemical Structure
  91. GC41173 15(R)-Pinane Thromboxane A2

    15-epi-Pinane Thromboxane A2, 15-iso-Pinane Thromboxane A2, 15(R)PTA2, 15-epi-PTA2, 15-iso-PTA2

     15(R)-Pinane thromboxane A2 is the (R)-epimer of pinane thromboxane A2. 15(R)-Pinane Thromboxane A2 Chemical Structure
  92. GC41166 15(S)-15-methyl Prostaglandin D2

    15(S)15methyl PGD2

     15(S)-15-methyl Prostaglandin D2 (15(S)-15-methyl PGD2) is a metabolically stable synthetic analog of PGD2. 15(S)-15-methyl Prostaglandin D2 Chemical Structure
  93. GC40452 15(S)-HETE MaxSpec® Standard 15(S)-HETE is a major arachidonic acid metabolite from the 15-lipoxygenase pathway. 15(S)-HETE MaxSpec® Standard Chemical Structure
  94. GC41102 15-deoxy-δ12,14-Prostaglandin D2

    15deoxyΔ12,14PGD2

     15-deoxy-δ12,14-PGD2 is a synthetic analog of PGD2 and a potential precursor to the PPARγ ligand 15-deoxy-δ12,14-PGJ2. 15-deoxy-δ12,14-Prostaglandin D2 Chemical Structure
  95. GC46443 15-deoxy-δ12,14-Prostaglandin D2-d4

    15-deoxy-Δ12,14-PGD2-d4

     A neuropeptide with diverse biological activities 15-deoxy-δ12,14-Prostaglandin D2-d4 Chemical Structure
  96. GC46444 15-deoxy-δ12,14-Prostaglandin D2-d9

    15-deoxy-Δ12,14-PGD2-d9

     A neuropeptide with diverse biological activities 15-deoxy-δ12,14-Prostaglandin D2-d9 Chemical Structure
  97. GC41103 15-keto Prostaglandin A1

    15keto PGA1

     Prostaglandin A1 (PGA1) was first isolated as a dehydration product of the PGE1 compounds found in human semen. 15-keto Prostaglandin A1 Chemical Structure
  98. GC41935 15-keto Treprostinil (sodium salt) 15-keto Treprostinil is an impurity found in treprostinil, which is a stable analog of prostaglandin I2 with a longer plasma half-life. 15-keto Treprostinil (sodium salt) Chemical Structure
  99. GC40973 16(R)-Iloprost Iloprost is a second generation structural analog of prostacyclin (PGI2) with about ten-fold greater potency than the first generation stable analogs, typified by carbaprostacyclin. 16(R)-Iloprost Chemical Structure
  100. GC40974 16(S)-Iloprost Iloprost is a second generation structural analog of prostacyclin (PGI2) with about ten-fold greater potency than the first generation stable analogs, typified by carbaprostacyclin. 16(S)-Iloprost Chemical Structure
  101. GC41159 16,16-dimethyl Prostaglandin D2

    16,16dimethyl PGD2

     16,16-dimethyl PGD2 is a metabolically stable synthetic analog of PGD2. 16,16-dimethyl Prostaglandin D2 Chemical Structure

Items 1 to 100 of 826 total

per page
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Descending Direction